Publication:
Minimal Residual Disease Response with Venetoclax Monotherapy in Relapsed/Refractory CLL Patients: VENICE I, Phase 3b Exploratory Analysis

Simple item page
dc.contributor.authorKater, Arnon
dc.contributor.authorPanagiotis, Panayiotidis
dc.contributor.authorAktan, Melih
dc.contributor.authorArslan, Onder
dc.contributor.authorDemirkan, Fatih
dc.contributor.authorEnggaard, Lisbeth
dc.contributor.authorForconi, Francesco
dc.date.accessioned2020-06-21T12:18:11Z
dc.date.available2020-06-21T12:18:11Z
dc.date.issued2020
dc.departmentOMÜen_US
dc.department-temp[Kater, Arnon] Univ Amsterdam, Amsterdam, Netherlands -- [Panagiotis, Panayiotidis] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Athens, Greece -- [Aktan, Melih] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey -- [Arslan, Onder] Ankara Univ, Ankara, Turkey -- [Demirkan, Fatih] Dokuz Eylul Univ, Div Hematol, Izmir, Turkey -- [Enggaard, Lisbeth] Herlev Hosp, Herlev, Denmark -- [Ferhanoglu, Burhan] Koc Univ, Sch Med, Istanbul, Turkeyen_US
dc.description.abstract…en_US
dc.identifier.endpage115en_US
dc.identifier.issn1042-8194
dc.identifier.issn1029-2403
dc.identifier.startpage113en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10129
dc.identifier.volume61en_US
dc.identifier.wosWOS:000534385400082
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.journalLeukemia & Lymphomaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleMinimal Residual Disease Response with Venetoclax Monotherapy in Relapsed/Refractory CLL Patients: VENICE I, Phase 3b Exploratory Analysisen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu